[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366337-105":59,"doc-detail-366337-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","systematic-pan-cancer-analysis-identified-ncoa4-as-an-immunological-and-prognostic-biomarker-and-validated-in-lung-adenocarcinoma","Systematic pan-cancer analysis identified NCOA4 as an immunological and prognostic biomarker and validated in lung adenocarcinoma","","Cancer immunotherapy has transformed treatment, but reliably predicting individual patient responses remains difficult. This study evaluates nuclear receptor coactivator 4 (NCOA4) as both an immunological and prognostic biomarker across multiple cancers, with special focus on lung adenocarcinoma (LUAD). Using pan-cancer public datasets, the analysis connects NCOA4 expression to survival, immune infiltration, genomic instability, and stemness, while including protein/network pathway enrichment and LUAD immunohistochemistry validation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/systematic-pan-cancer-analysis-identified-ncoa4-as-an-immunological-and-prognostic-biomarker-and-validated-in-lung-adenocarcinoma/366337/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/systematic-pan-cancer-analysis-identified-ncoa4-as-an-immunological-and-prognostic-biomarker-and-validated-in-lung-adenocarcinoma/366337.png","ImageObject",300,407,{"name":92,"@type":93},"Stanford","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is NCOA4 investigated in cancer immunotherapy?","Question",{"text":112,"@type":113},"NCOA4 has been suggested as a cancer biomarker, but its immunological and prognostic role across cancers—especially in lung adenocarcinoma—needs clarification for predicting immunotherapy-related outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were NCOA4 expression and prognostic effects assessed?",{"text":117,"@type":113},"The study analyzed NCOA4 expression in normal versus tumor tissues using CCLE, GTEx, and TCGA, then evaluated overall survival associations with univariate Cox regression and Kaplan–Meier analysis.",{"name":119,"@type":110,"acceptedAnswer":120},"What immune-related relationships did the study find for NCOA4?",{"text":121,"@type":113},"NCOA4 expression correlated with immune infiltration, including CD8+ T cells, neutrophils, and dendritic cells, and it was linked to genomic instability markers relevant to immunotherapy response.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366337,1790196563,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336477552062,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Wang et al. Discover Oncology (2025) 16:1422 [https://doi.org/10.1007/s12672-025-03064-3](https://doi.org/10.1007/s12672-025-03064-3)  \nDiscover Oncology  \nRESEARCH Open Access  \nSystematic pan-cancer analysis identified  NCOA4 as an immunological and prognostic biomarker and validated in lung adenocarcinoma  \nAn Wang 1,2†, Yun-ye Mao 1,2†, Tao Li 1,2,4,5†, Xin Zhou 1,2, Yi-bing Bai 1,2, Jia-pei Qin 1,2, Yi Dong 1,2, Ting Wang 1,2, Tong Zhang2,4*, Zhi-qiang Ma 1,3* and Yi Hu 1,2,3*  \n†An Wang, Yun-ye Mao and Tao Li contributed equally to this work.  \n*Correspondence:  \nTong Zhang [kqzhengji301@163.com](kqzhengji301@163.com)[ ](kqzhengji301@163.com)[Zhi-qiang Ma](Zhi-qiang Ma)[mazhiqiang@301hospital.com.cn](mazhiqiang@301hospital.com.cn)[ ](mazhiqiang@301hospital.com.cn)Yi Hu  \n[huyi301zlxb@sina.com](huyi301zlxb@sina.com)  \nFull list of author information is available at the end of the article  \nAbstract  \nBackground Cancer immunotherapy has revolutionized treatment, yet predicting patient responses remains challenging. The potential of nuclear receptor coactivator 4 (NCOA4) as a biomarker has been identified in different types of cancer. However, its role as an immunological and prognostic factor across cancers, particularly lung adenocarcinoma (LUAD), still needs to be fully understood. This study aims to address this gap by systematically analyzing NCOA4’s expression and its correlation with clinical outcomes and immune responses in pan-cancer.  \nObjective To evaluate NCOA4 as a prognostic biomarker and explore its association with immune microenvironments across different cancer types, specifically focusing on LUAD.  \nMethods We comprehensively analyzed data from the CCLE, GTEx, and TCGA databases. NCOA4 expression was analyzed in both normal and tumor tissues, and its correlation with overall survival was assessed using univariate Cox regression and Kaplan-Meier analysis. Immune infiltration was evaluated using the ESTIMATE, TIMER, and xCELL algorithms. We comprehensively analyzed its correlation with six genomic instability markers and the DNA methylation-and mRNA-based stemness index in certain tumors to investigate the potential role of NCOA4 in mediating cancer genomic heterogeneity and stemness. PPI network analysis and KEGG/GO enrichment analysis were conducted to identify associated proteins and pathways. LUAD samples were stained using immunohistochemistry (IHC) . TIDE algorithm was used to predict immune checkpoint blockade (ICB) response within theTCGA-LUAD cohort.  \nResults NCOA4 expression was significantly higher in tumor tissues than normal tissues in 18 cancer types, including LUAD, while it was lower in 5. Survival outcomesin specific cancers were found to be inversely associated with NCOA4 expression, as indicated by the results of univariate Cox regression and Kaplan-Meier analysis. Analysis of immune infiltration demonstrated a significant association between NCOA4 and the presence of immune cells, including CD8 + T cells, neutrophils, and  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this li","cbCaictQ9dDx4GME","https://ap.wps.com/l/cbCaictQ9dDx4GME","pdf",7247140,21,"English","# Abstract\n## Background\n## Objective\n## Methods\n## Results\n## Conclusion\n# Keywords\n## 1 Background","[{\"question\":\"Why is NCOA4 investigated in cancer immunotherapy?\",\"answer\":\"NCOA4 has been suggested as a cancer biomarker, but its immunological and prognostic role across cancers—especially in lung adenocarcinoma—needs clarification for predicting immunotherapy-related outcomes.\"},{\"question\":\"How were NCOA4 expression and prognostic effects assessed?\",\"answer\":\"The study analyzed NCOA4 expression in normal versus tumor tissues using CCLE, GTEx, and TCGA, then evaluated overall survival associations with univariate Cox regression and Kaplan–Meier analysis.\"},{\"question\":\"What immune-related relationships did the study find for NCOA4?\",\"answer\":\"NCOA4 expression correlated with immune infiltration, including CD8+ T cells, neutrophils, and dendritic cells, and it was linked to genomic instability markers relevant to immunotherapy response.\"}]","Systematic pan-cancer analysis identified NCOA4 as an immunological and prognostic biomarker and validated in lung adenocarcinoma | PDF",1790164877,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7be6fe94e2af61a891589ef6b46cee04.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/042cdb5f53e0aa33ecdf0b716ceca074.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e81e3f253ce31477bf7e83cf9b600fb2.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/842feae692d30b91ee48ee0f796cb0e2.webp",980,1306]